Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Weibing MIAO"'
Autor:
Guobing LIU, Weihai ZHUO, Yushen GU, Zhi YANG, Yue CHEN, Wei FAN, Jianming GUO, Jian TAN, Xiaohua ZHU, Li HUO, Xiaoli LAN, Biao LI, Weibing MIAO, Shaoli SONG, Hao XU, Rong TIAN, Quanyong LUO, Feng WANG, Xuemei WANG, Aimin YANG, Dong DAI, Zhiyong DENG, Jinhua ZHAO, Xiaoliang CHEN, Yan FAN, Zairong GAO, Xingmin HAN, Ningyi JIANG, Anren KUANG, Yansong LIN, Fugeng LIU, Cen LOU, Xinhui SU, Lijun TANG, Hui WANG, Xinlu WANG, Fuzhou YANG, Hui YANG, Xinming ZHAO, Bo YANG, Xiaodong HUANG, Jiliang CHEN, Sijin LI, Jing WANG, Yaming LI, Hongcheng SHI
Publikováno v:
Zhongguo Linchuang Yixue, Vol 31, Iss 5, Pp 844-850 (2024)
177Lu- prostate specific membrane antigen (PSMA) radio-ligand therapy has been approved abroad for advanced prostate cancer and has been in several clinical trials in China. Based on domestic clinical practice and experimental data and referred to in
Externí odkaz:
https://doaj.org/article/998c8708a63a4fc2ababe1785a01518f
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 9 (2022)
Purpose: This prospective trial aimed to evaluate the safety, dosimetry, and biodistribution of a novel theranostic probe 68Ga-DOTA-DiPSMA. Also, we have performed the first preliminary application with 68Ga-DOTA-DiPSMA in prostate cancer (PCa) patie
Externí odkaz:
https://doaj.org/article/d57b33788e3c4b64a70a2658c533bad1
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e111221 (2014)
99mTc-3PRGD2, a promising tracer targeting integrin receptor, may serve as a novel tumor-specific agent for single photon emission computed tomography (SPECT). A multi-center study was prospectively designed to evaluate the diagnostic accuracy of 99m
Externí odkaz:
https://doaj.org/article/825fb295194a42b5a015a2fdf5ffdbc8
Autor:
Jie Zang, Yun Yang, Shaoming Chen, Chao Wang, Shaohao Chen, Shun Hu, Hai Cai, Xiaodong Li, Ning Xu, Xiaoyuan Chen, Jingjing Zhang, Weibing Miao
Publikováno v:
Journal of Nuclear Medicine; Aug2024, Vol. 65 Issue 8, p1-6, 6p
Publikováno v:
Clinical Nuclear Medicine; Nov2024, Vol. 49 Issue 11, p1050-1052, 3p
Publikováno v:
Clinical Nuclear Medicine; Aug2024, Vol. 49 Issue 8, p790-792, 3p
Autor:
Ling Chen, Shan Zheng, Linying Chen, Sunwang Xu, Kunlin Wu, Lingjun Kong, Jiajie Xue, Xiangjin Chen, Weibing Miao, Youzhi Zhu
Publikováno v:
Journal of Nuclear Medicine; Dec2023, Vol. 64 Issue 12, p1899-1905, 7p
Autor:
Jieling Zheng, Feng Liu, KaiXian Lin, Li Zhang, Nan Huang, Wanjing Zheng, Jiaying Zhang, Shaobo Yao, Weibing Miao
Publikováno v:
Molecular Imaging and Biology. 24:973-985
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::892636292a7c48abb0bb28a44b1731d4
https://doi.org/10.1007/s11307-022-01748-8
https://doi.org/10.1007/s11307-022-01748-8
Publikováno v:
Annals of Nuclear Medicine. 36:610-622
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77539554612acfb3d5878f3b5e7629de
https://doi.org/10.1007/s12149-022-01742-8
https://doi.org/10.1007/s12149-022-01742-8
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 49:2960-2971
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5417c12bd3b0d98759bf60d6efbd253
https://doi.org/10.1007/s00259-022-05799-5
https://doi.org/10.1007/s00259-022-05799-5